EncoreSELECT-LIFE：一项非干预性随访研究旨在调查 SELECT 试验参与者中索玛鲁肽的长期疗效.pdf

1、1Department of Internal Medicine,Division of Endocrinology and Peter O Donnell Jr.School of Public Health,University of Texas Southwestern Medical Center,Dallas,TX,USA;2Institute of Cardiovascular Science,University College London,London,UK;3Novo Nordisk A/S,Sborg,Denmark;4VA Puget Sound Health Care

2、 System and University of Washington,Seattle,WA,USA;5Department of Cardiovascular Medicine,Cleveland Clinic,and Cleveland Clinic Lerner College of Medicine,Case Western Reserve University School of Medicine,Cleveland,OH,USA;6Division of Cardiovascular Medicine,Brigham and Womens Hospital,Harvard Med

3、ical School,Boston,MA,USA;7Pennington Biomedical Research Center,Baton Rouge,LA,USA.ldiko Lingvay declares having received research funding(paid to institution)and/or product from Novo Nordisk,Boehringer-Ingelheim,Dexcom,Roche,Pfizer,Lilly.She has also received research related consulting fees,inclu

4、ding support for attending meeting and/or travel(paid to institution)from Novo Nordisk;and advisory/consulting fees and/or other support from AbbVie,Altimmune,Alveus Therapeutics,Amgen,Antag Therapeutics,AstraZeneca,Bain Capital,Bayer,Betagenon AB,Bioio Inc,Biomea,Boehringer Ingelheim,Carmot,Corxel,

5、Cytoki Pharma,Eli Lilly,Genentech,Intercept,Janssen/Johnson&Johnson,Juvena,Keros Therapeutic Inc,Mediflix,Merck,Metsera,Neurocrine,Novo Nordisk,Pfizer,Regeneron,Roche,Sanofi,Shionogi,Source Bio,Structure Therapeutics,TERNS Pharma,The Comm Group,Verdiva Bio,WebMD,and Zealand Pharma.Ildiko Lingvay par

6、ticipates on the JAEB Center for Health board.This study was funded by Novo Nordisk A/S and is registered with ClinicalTrials.gov(NCT04972721).Editorial and administrative support was provided by Roxanna Munir,PhD,of Apollo,OPEN Health Communications,and funded by Novo Nordisk A/S,in accordance with